Knockdown of GDF15 inhibits endometrial cancer cell proliferation and EMT

Endometrial cancer (EC) is a malignant tumor affecting the uterine upper layer. Despite recent advancements, identifying new therapeutic targets remains important for improving patient prognosis. Growth differentiation factor 15 (GDF15) belongs to the Transforming Growth Factor (TGF)-β superfamily and is often upregulated in pathological conditions, including injury and cancers. However, its involvement in EC remains poorly understood. This study aims to elucidate the significance of GDF15 in EC and its potential underlying mechanism. Our results indicate increased GDF15 expression levels in EC tissues, and the knockdown of GDF15 was found to suppress EC cell growth and epithelial-mesenchymal transition (EMT). Moreover, GDF15 depletion inhibited the TGF-β pathway activation. In summary, GDF15 can promote EC cell growth and EMT by modulating the TGF-β/Smad2/Smad3 axis.

Endometrial cancer (EC); Growth differentiation factor 15 (GDF15); Growth; EMT; TGF-β/Smad2/Smad3 axis

[1] Khatun M, Urpilainen E, Ahtikoski A, Arffman RK, Pasanen A, Puistola U, et al. Low expression of stanniocalcin 1 (STC-1) protein is associated with poor clinicopathologic features of endometrial cancer. Pathology Oncology Research. 2021; 27: 1609936.

[2] Chen Y, You S, Li J, Zhang Y, Kokaraki G, Epstein E, et al. Follicular helper T-cell-based classification of endometrial cancer promotes precise checkpoint immunotherapy and provides prognostic stratification. Frontiers in Immunology. 2021; 12: 788959.

[3] Yang X, Li X, Cheng Y, Zhou J, Shen B, Zhao L, et al. Comprehensive analysis of the glycolysis-related gene prognostic signature and immune infiltration in endometrial cancer. Frontiers in Cell and Developmental Biology. 2021; 9: 797826.

[4] Kozłowski M, Borzyszkowska D, Mirko J, Turoń-Skrzypińska A, Piotrowska K, Tołoczko-Grabarek A, et al. Preoperative serum levels of PDGF-AB, PDGF-BB, TGF-α, EGF and ANG-2 in the diagnosis of endometrial cancer. Cancers. 2023; 15: 4815.

[5] Pölcher M, Rottmann M, Brugger S, Mahner S, Dannecker C, Kiechle M, et al. Lymph node dissection in endometrial cancer and clinical outcome: a population-based study in 5546 patients. Gynecologic Oncology. 2019; 154: 65–71.

[6] Wu H, Zhang J. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: a study based on TCGA data. Gynecologic Oncology. 2018; 149: 592–597.

[7] Tubridy EA, Taunk NK, Ko EM. Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy. Current Treatment Options in Oncology. 2024; 25: 330–345.

[8] Medina-Gutierrez E, Cespedes MV, Gallardo A, Rioja-Blanco E, Pavon MA, Asensio-Puig L, et al. Novel endometrial cancer models using sensitive metastasis tracing for CXCR4-targeted therapy in advanced disease. Biomedicines. 2022; 10: 1680.

[9] Ngamjariyawat A, Cen J, Wang X, Welsh N. GDF15 protects insulin-producing beta cells against pro-inflammatory cytokines and metabolic stress via increased deamination of intracellular adenosine. International Journal of Molecular Sciences. 2024; 25: 801.

[10] Lu JF, Zhu MQ, Xia B, Zhang NN, Liu XP, Liu H, et al. GDF15 is a major determinant of ketogenic diet-induced weight loss. Cell Metabolism. 2024; 36: 454–456.

[11] Joo M, Kim D, Lee MW, Lee HJ, Kim JM. GDF15 promotes cell growth, migration, and invasion in gastric cancer by inducing STAT3 activation. International Journal of Molecular Sciences. 2023; 24: 2925.

[12] Kim-Muller JY, Song L, LaCarubba Paulhus B, Pashos E, Li X, Rinaldi A, et al. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Reports. 2023; 42: 111947.

[13] Zhao X, Liu X, Hu S, Pan Y, Zhang J, Tai G, et al. GDF15 contributes to radioresistance by mediating the EMT and stemness of breast cancer cells. International Journal of Molecular Sciences. 2022; 23: 10911.

[14] Park H, Nam KS, Lee HJ, Kim KS. Ionizing radiation-induced GDF15 promotes angiogenesis in human glioblastoma models by promoting VEGFA expression through p-MAPK1/SP1 signaling. Frontiers in Oncology. 2022; 12: 801230.

[15] Li L, Zhang R, Yang H, Zhang D, Liu J, Li J, et al. GDF15 knockdown suppresses cervical cancer cell migration in vitro through the TGF-β/Smad2/3/Snail1 pathway. FEBS Open Bio. 2020; 10: 2750–2760.

[16] Lin H, Luo Y, Gong T, Fang H, Li H, Ye G, et al. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer. To be published in Cellular Oncology. 2024. [Preprint].

[17] Zheng X, Ma N, Wang X, Hu J, Ma X, Wang J, et al. Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis. Journal of Cancer. 2020; 11: 7116–7126.

[18] Kim J, Kim SH, Kang H, Lee S, Park SY, Cho Y, et al. TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response. Nature Metabolism. 2021; 3: 410–427.

[19] Tektonidou MG, Papassotiriou I, Sfikakis PP. Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome. Rheumatology. 2021; 61: 394–399.

[20] Rochette L, Zeller M, Cottin Y, Vergely C. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends in Endocrinology & Metabolism. 2021; 32: 875–889.

[21] Xiang X, Bhowmick K, Shetty K, Ohshiro K, Yang X, Wong LL, et al. Mechanistically based blood proteomic markers in the TGF-beta pathway stratify risk of hepatocellular cancer in patients with cirrhosis. Genes & Cancer. 2024; 15: 1–14.

[22] Fu Y, Zhou Y, Mu Y, Lv Y, Chen G, Zhang H, et al. Testicular orphan receptor 4 induced hepatic stellate cells activation via the regulation of TGF-β receptor Ⅰ/Smad2/3 signaling pathway. Annals of Hepatology. 2023; 28: 100775.

[23] Wang P, Zhang T, Jiang N, Wang K, Feng L, Liu T, et al. PDIA6, which is regulated by TRPM2-AS/miR-424-5p axis, promotes endometrial cancer progression via TGF-beta pathway. Cell Death & Disease. 2023; 14: 829.

[24] Zhao T, Sun R, Ma X, Wei L, Hou Y, Song K, et al. Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating the TGF/β-Smad2/3 signaling pathway. Acta Biochimica et Biophysica Sinica. 2022; 54: 904–916.

[25] Park HN, Song MJ, Choi YE, Lee DH, Chung JH, Lee ST. LRG1 Promotes ECM integrity by activating the TGF-β signaling pathway in fibroblasts. International Journal of Molecular Sciences. 2023; 24: 12445.

[26] Zhang Q, Fong CC, Yu WK, Chen Y, Wei F, Koon CM, et al. Herbal formula Astragali Radix and Rehmanniae Radix exerted wound healing effect on human skin fibroblast cell line Hs27 via the activation of transformation growth factor (TGF-β) pathway and promoting extracellular matrix (ECM) deposition. Phytomedicine. 2012; 20: 9–16.